Lexaria Bioscience Corp. - LEXX
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$1.314M
QoQ value delta ($000)
+$269K
(+25.74%)
Implied price effect (QoQ)
+22.28%
Shares
Total shares
1,749,425
QoQ shares delta
+48,215
(+2.83%)
Total shares held by funds (by quarter)
Market chart (LEXX)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 28 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Invenomic Capital Management LP | 344 | 442,301 | 0.02% |
| GEODE CAPITAL MANAGEMENT, LLC | 229 | 294,157 | 0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 173 | 222,293 | 0.0% |
| VANGUARD GROUP INC | 159 | 258,816 | 0.0% |
| TORONTO DOMINION BANK | 109 | 140,013 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 73 | 94,166 | 0.0% |
| UBS Group AG | 41 | 52,708 | 0.0% |
| STATE STREET CORP | 30 | 39,301 | 0.0% |
| BlackRock, Inc. | 21 | 27,445 | 0.0% |
| Krilogy Financial LLC | 19 | 19,653 | 0.0% |
| XTX Topco Ltd | 19 | 25,067 | 0.0% |
| Vontobel Holding Ltd. | 17 | 23,000 | 0.0% |
| NORTHERN TRUST CORP | 14 | 18,389 | 0.0% |
| HRT FINANCIAL LP | 14 | 18,465 | 0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 12 | 16,300 | 0.0% |
| BANK OF MONTREAL /CAN/ | 10 | 14,033 | 0.0% |
| CITADEL ADVISORS LLC | 10 | 13,513 | 0.0% |
| Vanguard Global Advisers, LLC | 7 | 10,204 | 0.0% |
| BCV Asset Management Inc. | 7 | 10,000 | 0.0% |
| ROYAL BANK OF CANADA | 6 | 7,140 | 0.0% |
| MORGAN STANLEY | 0 | 3 | 0.0% |
| Tower Research Capital LLC (TRC) | 0 | 2 | 0.0% |
| OSAIC HOLDINGS, INC. | 0 | 605 | 0.0% |
| GABLES CAPITAL MANAGEMENT INC. | 0 | 13 | 0.0% |
| Byrne Asset Management LLC | 0 | 800 | 0.0% |